 | Up a level |
Hitz, F.; Ribi, K.; Li, Qiyu; Klingbiel, Dirk; Cerny, T.; Koeberle, D. (2013). Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer. Supportive care in cancer, 21(11), pp. 3085-3093. Springer 10.1007/s00520-013-1886-4
Ghielmini, M.; Rufibach, K.; Salles, G.; Leoncini-Franscini, L.; Léger-Falandry, C.; Cogliatti, S.; Fey, M.; Martinelli, G.; Stahel, R.; Lohri, A.; Ketterer, N.; Wernli, M.; Cerny, T.; Hsu Schmitz, S.-F. (2005). Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology, 16(10), pp. 1675-1682. Oxford University Press 10.1093/annonc/mdi320
Von Rohr, A.; Schmitz, S.-F. H.; Tichelli, A.; Hess, U.; Piguet, D.; Wernli, M.; Frickhofen, N.; Konwalinka, G.; Zulian, G.; Ghielmini, M.; Rufener, B.; Racine, C.; Fey, M. F.; Cerny, T.; Betticher, D.; Tobler, A. (2002). Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study. Annals of oncology, 13(10), pp. 1641-1649. Oxford University Press 10.1093/annonc/mdf272
Buetler, T. M.; Wilder-Smith, O. H. G.; Wilder-Smith, C. H.; Aebi, S.; Cerny, T.; Brenneisen, R. (2000). Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British journal of anaesthesia, 84(1), pp. 97-99. Oxford University Press 10.1093/oxfordjournals.bja.a013391
Cerny, T.; Leyvraz, S.; Von Briel, T.; Küpfer, A.; Schaad, R.; Hsu Schmitz, S.-F.; Honegger, P.; Sessa, C.; Brunner, J.; Boddy, A. V. (1999). Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients. Annals of oncology, 10(9), pp. 1087-1094. Oxford University Press 10.1023/A:1008386000547
Betticher, D. C.; Ratschiller, D.; Hsu Schmitz, S.-F.; Von Rohr, A.; Hess, U.; Zulian, G.; Wernli, M.; Tichelli, A.; Tobler, A.; Fey, M. F.; Cerny, T. (1998). Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Annals of oncology, 9(7), pp. 721-726. Oxford University Press 10.1023/A:1008273131598
Stupp, R.; Bauer, J.; Pagani, O.; Gerard, B.; Cerny, T.; Sessa, C.; Bastian, G.; Sarkany, M.; Schläpfer, J.; Giroux, B.; Leyvraz, S. (1998). Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of oncology, 9(11), pp. 1233-1242. Oxford University Press 10.1023/A:1008495919071
Als, C.; Laeng, H.; Cerny, T.; Kinser, J. A.; Rösler, H.; Häusler, R. (1998). Primary cervical malignant teratoma with a rib metastasis in an adult: Five-year survival after surgery and chemotherapy. Annals of oncology, 9(9), pp. 1015-1022. Oxford University Press 10.1023/A:1008277227111
Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A. (1997). Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation. Annals of oncology, 8(6), pp. 604-606. Oxford University Press 10.1023/A:1008245709924
